
Onglyza
Brand for: Saxagliptin
My Prescription
Payment
Select pharmacy




$45.54
Print or send this coupon to your phone
About Onglyza
Drug Details
Saxagliptin is a medication used to manage high blood sugar levels in adults with type 2 diabetes, in conjunction with a healthy diet and regular exercise. By effectively controlling blood sugar, saxagliptin helps reduce the risk of serious complications such as kidney damage, vision problems, nerve issues, limb loss, and sexual dysfunction. It may also lower the chances of experiencing a heart attack or stroke. Saxagliptin belongs to a class of drugs known as dipeptidyl peptidase-4 (DPP-4) inhibitors. It functions by blocking the DPP-4 enzyme, which breaks down incretin hormones that stimulate insulin production. This action results in prolonged insulin activity, particularly after meals, and reduces the amount of sugar produced by the liver. Saxagliptin is typically taken orally once a day. While the brand name Onglyza is no longer available, generic versions of the medication are accessible. Some potential side effects include infections and headaches. Always consult with a healthcare professional before starting any new medication.
Onglyza (Saxagliptin) dosage forms
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 2.5MG | 30 Tablets | $53.59 | $1.79 |
| 2.5MG | 90 Tablets | $126.78 | $1.41 |
| 5MG | 30 Tablets | $50.26 | $1.68 |
| 5MG | 90 Tablets | $116.78 | $1.30 |
Onglyza FAQs
Onglyza and Januvia are not the same, but they are similar in that both are medications used to manage type 2 diabetes. They belong to the same class of drugs known as DPP-4 inhibitors, which help to lower blood sugar levels. However, they contain different active ingredients; Onglyza contains saxagliptin, while Januvia contains sitagliptin. It is important for patients to follow their healthcare provider's recommendations regarding which medication is appropriate for their specific condition.
As of the latest available information, Onglyza (saxagliptin) has not been discontinued. It remains available as a prescription medication for the management of type 2 diabetes. However, availability can vary by region, so it is advisable to check with local pharmacies or healthcare providers for the most current information.
Onglyza is used to help control blood sugar levels in adults with type 2 diabetes. It is typically used in conjunction with diet and exercise to improve glycemic control.
Onglyza (saxagliptin) is not typically associated with weight gain. In fact, it is generally considered weight-neutral, meaning it does not significantly affect a person's weight. However, individual responses to medication can vary, and any concerns about weight changes should be discussed with a healthcare provider.
Onglyza (saxagliptin) and Januvia (sitagliptin) are both medications used to manage type 2 diabetes. They belong to a class of drugs called DPP-4 inhibitors, which help increase insulin production and decrease glucose production in the liver. The primary difference between the two lies in their active ingredients and their specific pharmacokinetic profiles, which may affect how they are metabolized and excreted in the body. Additionally, they may have different side effect profiles and interactions with other medications. It is important for patients to consult with their healthcare provider to determine which medication is more suitable for their individual needs.